Literature DB >> 34593607

Quantitative Longitudinal Imaging Reveals that Inhibiting Hedgehog Activity Alleviates the Hypoxic Tumor Landscape.

Tshering D Lama-Sherpa1, Shamik Das1, Dominique C Hinshaw1, Sarah C Kammerud1, Patrick N Song2, Heba A Alsheikh1, Anna G Sorace2,3, Rajeev S Samant1,3,4, Lalita A Shevde5,3.   

Abstract

Metastases account for the majority of mortalities related to breast cancer. The onset and sustained presence of hypoxia strongly correlates with increased incidence of metastasis and unfavorable prognosis in patients with breast cancer. The Hedgehog (Hh) signaling pathway is dysregulated in breast cancer, and its abnormal activity enables tumor progression and metastasis. In addition to programming tumor cell behavior, Hh activity enables tumor cells to craft a metastasis-conducive microenvironment. Hypoxia is a prominent feature of growing tumors that impacts multiple signaling circuits that converge upon malignant progression. We investigated the role of Hh activity in crafting a hypoxic environment of breast cancer. We used radioactive tracer [18F]-fluoromisonidazole (FMISO) positron emission tomography (PET) to image tumor hypoxia. We show that tumors competent for Hh activity are able to establish a hypoxic milieu; pharmacologic inhibition of Hh signaling in a syngeneic mammary tumor model mitigates tumor hypoxia. Furthermore, in hypoxia, Hh activity is robustly activated in tumor cells and institutes increased HIF signaling in a VHL-dependent manner. The findings establish a novel perspective on Hh activity in crafting a hypoxic tumor landscape and molecularly navigating the tumor cells to adapt to hypoxic conditions. IMPLICATIONS: Importantly, we present a translational strategy of utilizing longitudinal hypoxia imaging to measure the efficacy of vismodegib in a preclinical model of triple-negative breast cancer. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34593607      PMCID: PMC8738112          DOI: 10.1158/1541-7786.MCR-21-0257

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   6.333


  52 in total

1.  Tumor hypoxia and malignant progression.

Authors:  Peter Vaupel; Arnulf Mayer; Michael Höckel
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

2.  Activating CCT2 triggers Gli-1 activation during hypoxic condition in colorectal cancer.

Authors:  Seong Hye Park; Soyeon Jeong; Bo Ram Kim; Yoon A Jeong; Jung Lim Kim; Yoo Jin Na; Min Jee Jo; Hye Kyeong Yun; Dae Yeong Kim; Bu Gyeom Kim; Dae-Hee Lee; Sang Cheul Oh
Journal:  Oncogene       Date:  2019-08-28       Impact factor: 9.867

Review 3.  Nontransgenic models of breast cancer.

Authors:  G H Heppner; F R Miller; P M Shekhar
Journal:  Breast Cancer Res       Date:  2000-08-04       Impact factor: 6.466

4.  Down-regulation of FOXR2 inhibits hypoxia-driven ROS-induced migration and invasion of thyroid cancer cells via regulation of the hedgehog pathway.

Authors:  Chong-Wu Liao; Chen Zheng; Le Wang
Journal:  Clin Exp Pharmacol Physiol       Date:  2020-03-11       Impact factor: 2.557

Review 5.  Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.

Authors:  William G Kaelin; Peter J Ratcliffe
Journal:  Mol Cell       Date:  2008-05-23       Impact factor: 17.970

Review 6.  Molecular mechanisms mediating metastasis of hypoxic breast cancer cells.

Authors:  Gregg L Semenza
Journal:  Trends Mol Med       Date:  2012-08-23       Impact factor: 11.951

7.  PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a).

Authors:  Brooke M Emerling; Frank Weinberg; Juinn-Lin Liu; Tak W Mak; Navdeep S Chandel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

Review 8.  Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer.

Authors:  Hao Xie; Brooke D Paradise; Wen Wee Ma; Martin E Fernandez-Zapico
Journal:  Cells       Date:  2019-04-29       Impact factor: 6.600

Review 9.  Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics.

Authors:  G L Semenza
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

Review 10.  Glucose Metabolism on Tumor Plasticity, Diagnosis, and Treatment.

Authors:  Xiaoping Lin; Zizheng Xiao; Tao Chen; Steven H Liang; Huiqin Guo
Journal:  Front Oncol       Date:  2020-03-06       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.